Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 24% ± 8% | |
epithelial cell | 6 studies | 32% ± 14% | |
natural killer cell | 5 studies | 18% ± 2% | |
fibroblast | 4 studies | 19% ± 5% | |
ciliated cell | 4 studies | 26% ± 8% | |
goblet cell | 4 studies | 20% ± 4% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 1% | |
non-classical monocyte | 3 studies | 30% ± 6% | |
abnormal cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6206.32 | 1445 / 1445 | 100% | 43.70 | 183 / 183 |
uterus | 100% | 5479.42 | 170 / 170 | 100% | 63.93 | 459 / 459 |
brain | 100% | 4573.34 | 2638 / 2642 | 100% | 54.49 | 705 / 705 |
thymus | 100% | 5679.25 | 653 / 653 | 100% | 53.27 | 604 / 605 |
skin | 100% | 6361.46 | 1809 / 1809 | 100% | 46.84 | 471 / 472 |
pancreas | 100% | 2482.09 | 327 / 328 | 100% | 61.20 | 178 / 178 |
kidney | 100% | 5733.79 | 89 / 89 | 100% | 51.78 | 898 / 901 |
ovary | 100% | 4368.22 | 180 / 180 | 100% | 32.31 | 428 / 430 |
intestine | 100% | 5990.61 | 966 / 966 | 99% | 65.91 | 524 / 527 |
bladder | 100% | 5614.00 | 21 / 21 | 99% | 67.86 | 501 / 504 |
prostate | 100% | 6620.26 | 245 / 245 | 99% | 53.10 | 499 / 502 |
lung | 100% | 5106.40 | 578 / 578 | 99% | 49.87 | 1147 / 1155 |
stomach | 100% | 4294.24 | 359 / 359 | 99% | 54.57 | 284 / 286 |
breast | 100% | 4825.44 | 459 / 459 | 99% | 50.76 | 1107 / 1118 |
liver | 100% | 3045.16 | 226 / 226 | 99% | 28.59 | 402 / 406 |
adrenal gland | 100% | 4810.81 | 258 / 258 | 99% | 40.26 | 227 / 230 |
adipose | 100% | 4537.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 43.47 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 61.98 | 29 / 29 |
spleen | 100% | 6035.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 59.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 89.34 | 1 / 1 |
blood vessel | 100% | 4817.57 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3578.48 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 3056.68 | 857 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6030.72 | 920 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0051469 | Biological process | vesicle fusion with vacuole |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0061763 | Biological process | multivesicular body-lysosome fusion |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_0045324 | Biological process | late endosome to vacuole transport |
GO_0051301 | Biological process | cell division |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0061952 | Biological process | midbody abscission |
GO_0090148 | Biological process | membrane fission |
GO_0006997 | Biological process | nucleus organization |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0010824 | Biological process | regulation of centrosome duplication |
GO_0046761 | Biological process | viral budding from plasma membrane |
GO_1902774 | Biological process | late endosome to lysosome transport |
GO_0032509 | Biological process | endosome transport via multivesicular body sorting pathway |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_1904903 | Biological process | ESCRT III complex disassembly |
GO_0007076 | Biological process | mitotic chromosome condensation |
GO_0015031 | Biological process | protein transport |
GO_0006914 | Biological process | autophagy |
GO_0097352 | Biological process | autophagosome maturation |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031468 | Biological process | nuclear membrane reassembly |
GO_0000815 | Cellular component | ESCRT III complex |
GO_0030496 | Cellular component | midbody |
GO_0005643 | Cellular component | nuclear pore |
GO_0005886 | Cellular component | plasma membrane |
GO_0012505 | Cellular component | endomembrane system |
GO_0005769 | Cellular component | early endosome |
GO_0000776 | Cellular component | kinetochore |
GO_0005815 | Cellular component | microtubule organizing center |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005828 | Cellular component | kinetochore microtubule |
GO_0005829 | Cellular component | cytosol |
GO_0005771 | Cellular component | multivesicular body |
GO_1904930 | Cellular component | amphisome membrane |
GO_0000794 | Cellular component | condensed nuclear chromosome |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CHMP1A |
Protein name | Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a) (Vacuolar protein sorting-associated protein 46-1) (Vps46-1) (hVps46-1) Charged multivesicular body protein 1A |
Synonyms | CHMP1 KIAA0047 PRSM1 PCOLN3 |
Description | FUNCTION: Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Involved in cytokinesis. Involved in recruiting VPS4A and/or VPS4B to the midbody of dividing cells. May also be involved in chromosome condensation. Targets the Polycomb group (PcG) protein BMI1/PCGF4 to regions of condensed chromatin. May play a role in stable cell cycle progression and in PcG gene silencing. . |
Accessions | A0A6Q8PHU0 ENST00000674799.1 A0A6Q8PGM8 Q9HD42 A0A6Q8PG85 ENST00000675942.1 A0A6Q8PGI9 ENST00000550102.5 F8VUA2 ENST00000675909.1 F5H875 ENST00000535997.7 ENST00000675778.1 ENST00000549328.2 A0A6Q8PF26 ENST00000675309.1 A0A6Q8PF35 ENST00000676355.1 ENST00000676118.1 A0A6Q8PFF8 ENST00000676402.1 F8VVT7 A0A6Q8PFX8 ENST00000397901.8 [Q9HD42-1] ENST00000675536.1 ENST00000675016.1 A0A6Q8PGV2 A0A6Q8PFF9 ENST00000675161.1 |